Overview


According to FutureWise analysis the market for minimally invasive surgical instruments in 2023 is US$ 23.4 billion, and is expected to reach US$ 42.1 billion by 2031 at a CAGR of 7.62%.

Electrosurgical systems, robot-assisted surgical systems, and surgical equipment are all examples of minimally invasive surgical instruments that are used during the process. Minimally invasive surgery is any surgical treatment that is carried out through a series of small incisions rather than a major incision, resulting in a faster recovery, less blood loss, and less discomfort than traditional open surgery. Minimally Invasive Surgery (MIS) is a type of surgery that uses smaller incisions in the patient's body to treat a disease or condition, resulting in less trauma and a quicker recovery period. Robotic surgery and non-robotic minimally invasive surgery are two types of minimally invasive procedures. The use of minimally invasive surgery is linked to reduced pain, fewer problems, and a shorter stay in the hospital. Minimally invasive surgical procedures are used in operations such as cardiothoracic surgery, gastric reflux disease, gastroenterology, gynaecological surgery, heart surgery, paediatric surgery, urogynecology and pelvic reconstructive surgery, and urological surgery. Minimally invasive surgery can be used for both diagnostic and therapeutic procedures. During the forecast period, the market is expected to rise due to rising prevalence of chronic diseases and rising demand for less invasive procedures. Furthermore, new product approval and rising chronic illness incidences are likely to boost market growth.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Minimally Invasive Surgical Instruments Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Minimally Invasive Surgical Instruments Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Medtronic plc.
  • Johnson and Johnson
  • Stryker Corporation
  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • CONMED Corporation
  • Smith and Nephew plc.
  • Zimmer Biomet Holdings, Inc.
  • Becton, Dickinson and Company
  • The Cooper Companies Inc.
  • HOYA Corporation
  • Surgical Innovations Group plc.
  • Koninklijke Philips N.V.
  • FUJIFILMHoldings Corporation
  • KARL STORZ SECo. KG
  • Applied Medical Resources Corporation
  • KLS Martin Group
  • Scanlan International, Inc.
  • Wexler Surgical
  • Strauss Surgical
  • Amnotec International Medical Gmbh
  • Endomed Systems Gmbh
  • Trokamed Gmbh
  • Surgical Holdings

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Handheld Instruments
    • Graspers
    • Retractors/Elevators
    • Suturing Instruments
    • Dilators
    • Other Handheld Instruments
  • Inflation Devices
    • Balloons
    • Balloon Inflation Devices
  • Surgical Scopes
    • Laparoscopes
    • Urology Endoscopes
    • Arthroscopes
    • Neuroendoscopes
    • Other Surgical Scopes
  • Cutting Instruments
    • Trocars
    • Other Cutting Instruments
  • Guiding Devices
    • Guiding Catheters
    • Guidewires
  • Electrosurgical and Electrocautery Instruments
    • Electrosurgical Instruments
    • Electrocautery Devices
  • Other Instruments

By Type of Surgery

  • Cardiothoracic Surgery
  • Gastrointestinal Surgery
  • Orthopedic Surgery
  • Gynecological Surgery
  • Cosmetic and Bariatric Surgery
  • Urological Surgery
  • Other Surgeries

By End User

  • Hospitals and Specialty Clinics
  • Ambulatory Surgery Centers

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Minimally Invasive Surgical Instruments Market By Product, By Type of Surgery, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Minimally Invasive Surgical Instruments Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Minimally Invasive Surgical Instruments Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Minimally Invasive Surgical Instruments Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Minimally Invasive Surgical Instruments Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Handheld Instruments
         1.1. Graspers
         1.2. Retractors/Elevators
         1.3. Suturing Instruments
         1.4. Dilators
         1.5. Other Handheld Instruments
        2. Inflation Devices
         2.1. Balloons
         2.2. Balloon Inflation Devices
        3. Surgical Scopes
         3.1. Laparoscopes
         3.2. Urology Endoscopes
         3.3. Arthroscopes
         3.4. Neuroendoscopes
         3.5. Other Surgical Scopes
        4. Cutting Instruments
         4.1. Trocars
         4.2. Other Cutting Instruments
        5. Guiding Devices
         5.1. Guiding Catheters
         5.2. Guidewires
        6. Electrosurgical and Electrocautery Instruments
         1. Electrosurgical Instruments
         2. Electrocautery Devices
        7. Other Instruments

  • 8.   Minimally Invasive Surgical Instruments Market, By Type of Surgery Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Cardiothoracic Surgery
        2. Gastrointestinal Surgery
        3. Orthopedic Surgery
        4. Gynecological Surgery
        5. Cosmetic and Bariatric Surgery
        6. Urological Surgery
        7. Other Surgeries

  • 9.   Minimally Invasive Surgical Instruments Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals and Specialty Clinics
        2. Ambulatory Surgery Centers

  • 10.   North America Minimally Invasive Surgical Instruments Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Minimally Invasive Surgical Instruments Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Minimally Invasive Surgical Instruments Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Minimally Invasive Surgical Instruments Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Medtronic plc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Johnson and Johnson
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Stryker Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Abbott Laboratories, Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Boston Scientific Corporation
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. B. Braun Melsungen AG
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. CONMED Corporation
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Smith and Nephew plc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
           9. Zimmer Biomet Holdings, Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
              10. Becton, Dickinson and Company
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
              11. The Cooper Companies Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
              12. HOYA Corporation
              12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
              13. Surgical Innovations Group plc
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
              14. Koninklijke Philips N.V.
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
              15. FUJIFILMHoldings Corporation
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
              16. KARL STORZ SECo. KG
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
              17. Applied Medical Resources Corporation
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
              18. KLS Martin Group
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
              19. Scanlan International, Inc.
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
              20. Wexler Surgical
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview
              21. Strauss Surgical
         21.1. Company Overview
         21.2. Product Portfolio
         21.3. SWOT Analysis
         21.4. Financial Overview
         21.5. Strategic Overview
              22. Amnotec International Medical Gmbh
         22.1. Company Overview
         22.2. Product Portfolio
         22.3. SWOT Analysis
         22.4. Financial Overview
         22.5. Strategic Overview
              23. Endomed Systems Gmbh
         23.1. Company Overview
         23.2. Product Portfolio
         23.3. SWOT Analysis
         23.4. Financial Overview
         23.5. Strategic Overview
              24. Trokamed Gmbh
         24.1. Company Overview
         24.2. Product Portfolio
         24.3. SWOT Analysis
         24.4. Financial Overview
         24.5. Strategic Overview
        25. Surgical Holdings
         25.1. Company Overview
         25.2. Product Portfolio
         25.3. SWOT Analysis
         25.4. Financial Overview
         25.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients